GoodRx Holdings, Inc. - Class A Common Stock (NQ:GDRX)

3.355 +0.075 (+2.29%)

Delayed Quote Updated: 2:04 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about GoodRx Holdings, Inc. - Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

22 23 Next >

3 Reasons to Avoid GDRX and 1 Stock to Buy Instead

Today 0:03 EDT

What a fantastic six months it’s been for GoodRx. Shares of the company have skyrocketed 58.7%, hitting $3.29. This was partly thanks to its solid quarterly ...

Via StockStory

Topics Supply Chain

1 Value Stock to Target This Week and 2 That Underwhelm

September 29, 2026

Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The ...

Via StockStory

3 of Wall Street’s Favorite Stocks We Approach with Caution

September 14, 2026

Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remember...

Via StockStory

From Kids to Canines: GoodRx Launches Companion Family Plan to Bring Healthcare Savings to the Whole Household

September 03, 2026

From GoodRx

Via Business Wire

GoodRx (NASDAQ:GDRX) Q2 2026: Subscription and Pharma Direct Growth Lift Shares Despite Revenue Decline ↗

August 05, 2026

Via Chartmill

1 Momentum Stock with Exciting Potential and 2 That Underwhelm

September 01, 2026

The stocks featured in this article are seeing some big returns. Over the past month, they’ve outpaced the market due to some combination of positive news, u...

Via StockStory

GoodRx (GDRX) Q2 2026 Earnings Call Transcript ↗

August 12, 2026

Pharma Direct revenue surged 76% as GLP-1 demand accelerated.

Via The Motley Fool

Topics Earnings

Reflecting On Healthcare Technology Stocks’ Q2 Earnings: GoodRx (NASDAQ:GDRX)

August 11, 2026

Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look at GoodRx (NASDAQ:GDRX) and its ...

Via StockStory

1 Small-Cap Stock with Solid Fundamentals and 2 Facing Headwinds

August 11, 2026

Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that ...

Via StockStory

GDRX Q2 Deep Dive: Pharma Direct and Subscription Growth Drive Upgraded Outlook

August 07, 2026

Healthcare tech company GoodRx (NASDAQ:GDRX) reported Q2 CY2026 results beating Wall Street’s revenue expectations, but sales fell by 1.3% year on year to $2...

Via StockStory

Topics Artificial Intelligence

1 Stock Under $10 with Exciting Potential and 2 Facing Headwinds

August 07, 2026

Investors can certainly boost their returns by concentrating on stocks trading between $1 and $10. However, a disciplined approach is necessary because many ...

Via StockStory

GoodRx Q2 Earnings Call Highlights ↗

August 06, 2026

GoodRx (NASDAQ:GDRX) reported second-quarter 2026 revenue of $200.4 million and adjusted EBITDA of $63.7 million, representing a 31.8% adjusted EBITDA margin, as growth in its Pharma Direct and...

Via MarketBeat

Topics Earnings

GoodRx (NASDAQ:GDRX) Reports Upbeat Q2 CY2026, Stock Soars

August 05, 2026

Healthcare tech company GoodRx (NASDAQ:GDRX) reported Q2 CY2026 results exceeding the market’s revenue expectations, but sales fell by 1.3% year on year to $...

Via StockStory

GoodRx Reports Second Quarter 2026 Results

August 05, 2026

From GoodRx Holdings, Inc.

Via Business Wire

GoodRx Earnings: What To Look For From GDRX

August 03, 2026

Healthcare tech company GoodRx (NASDAQ:GDRX) will be reporting results this Wednesday after the bell. Here’s what investors should know. GoodRx beat analysts...

Via StockStory

1 Cash-Producing Stock for Long-Term Investors and 2 We Avoid

July 24, 2026

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff...

Via StockStory

GoodRx (GDRX): Buy, Sell, or Hold Post Q1 Earnings?

July 21, 2026

GoodRx has had an impressive run over the past six months as its shares have beaten the S&P 500 by 13.1%. The stock now trades at $3.14, marking a 21.5% gain...

Via StockStory

Topics Stocks Supply Chain

1 Profitable Stock for Long-Term Investors and 2 Facing Challenges

July 17, 2026

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does...

Via StockStory

Stocks making big moves yesterday: RXO, Progyny, Cigna, GoodRx, and Domino's

July 14, 2026

Check out the companies making headlines yesterday: RXO (NYSE:RXO): Freight Delivery Company RXO (NYSE:RXO) rose by 4.2% on Monday after Stifel raised its pr...

Via StockStory

GoodRx (GDRX) Stock Trades Up, Here Is Why

July 13, 2026

What Happened? Shares of healthcare tech company GoodRx (NASDAQ:GDRX) jumped 2.6% in the afternoon session after the company announced a partnership with Pay...

Via StockStory

GoodRx Announces Date for Second Quarter 2026 Earnings Release and Conference Call

July 09, 2026

From GoodRx Holdings, Inc.

Via Business Wire

1 Mooning Stock to Target This Week and 2 That Underwhelm

July 09, 2026

Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of positive catalysts such as a ne...

Via StockStory

2 Healthcare Stocks to Consider Right Now and 1 We Brush Off

June 25, 2026

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Players catalyzing medical advanceme...

Via StockStory

Q1 Earnings Highlights: GoodRx (NASDAQ:GDRX) Vs The Rest Of The Healthcare Technology Stocks

June 16, 2026

As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the healthcare technology industry, includ...

Via StockStory

1 Stock Under $10 to Target This Week and 2 We Find Risky

June 12, 2026

Stocks trading in the $1-10 range are generally smaller players with less risk than their penny stock counterparts. But that doesn’t mean the underlying busi...

Via StockStory

1 Small-Cap Stock with Competitive Advantages and 2 We Ignore

June 05, 2026

Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that ...

Via StockStory

GoodRx Launches GoodRx Companion, a New Subscription Designed to Lower Everyday Healthcare Costs

May 27, 2026

From GoodRx

Via Business Wire

3 Value Stocks That Fall Short

May 15, 2026

Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The ...

Via StockStory

GoodRx, RadNet, Addus HomeCare, Novavax, and Mettler-Toledo Shares Plummet, What You Need To Know

May 13, 2026

What Happened? A number of stocks fell in the afternoon session after the April PPI report showed wholesale inflation accelerating to 6% annually, with servi...

Via StockStory

Topics Economy

The 5 Most Interesting Analyst Questions From GoodRx’s Q1 Earnings Call

May 13, 2026

GoodRx saw a positive market reaction to its first-quarter results, with management attributing performance to robust growth in its Pharma Direct segment and...

Via StockStory

Topics Earnings

< Previous 1 2 3 4 5 6 7 8 9

...

22 23 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.